Ballentine Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,346
| Closed | -$301K | – | 1073 |
|
|
2025
Q1 | $301K | Buy |
1,346
+445
| +49% | +$99.6K | 0.01% | 626 |
|
|
2024
Q4 | $295K | Buy |
901
+135
| +18% | +$44.2K | 0.01% | 596 |
|
|
2024
Q3 | $230K | Buy |
766
+24
| +3% | +$7.2K | ﹤0.01% | 699 |
|
|
2024
Q2 | $244K | Buy |
742
+33
| +5% | +$10.9K | ﹤0.01% | 621 |
|
|
2024
Q1 | $281K | Sell |
709
-31
| -4% | -$12.3K | 0.01% | 553 |
|
|
2023
Q4 | $261K | Sell |
740
-193
| -21% | -$68K | 0.01% | 546 |
|
|
2023
Q3 | $350K | Buy |
933
+19
| +2% | +$7.13K | 0.01% | 400 |
|
|
2023
Q2 | $350K | Sell |
914
-1
| -0.1% | -$382 | 0.01% | 409 |
|
|
2023
Q1 | $317K | Buy |
+915
| New | +$317K | 0.01% | 403 |
|
|
2022
Q2 | – | Sell |
-658
| Closed | -$270K | – | 490 |
|
|
2022
Q1 | $270K | Buy |
658
+158
| +32% | +$64.8K | 0.01% | 373 |
|
|
2021
Q4 | $235K | Buy |
+500
| New | +$235K | 0.01% | 416 |
|